Earnings History Data for Centessa Pharmaceuticals plc (CNTA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc is a clinical-stage company employing its innovative asset-centric business model to discover, develop and ultimately deliver impactful medicines to patients. Centessa Pharmaceuticals plc is based in Cambridge, United Kingdom.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12-11-2024 | PM | CNTA | Centessa Pharmaceuticals plc | 1,830 | -0.37 | -0.42 | -0.40 | Centessa Pharmaceuticals GAAP EPS of -$0.37 [11/12/2024 9:50 AM] |
17.00 | 0.27 (1.61%) |
16.73 | 0.0 (0.00%) |
5.58 - 17.79 | 1,609,088 | 350,000 | 2,557 | ||
13-08-2024 | PM | CNTA | Centessa Pharmaceuticals plc | 1,290 | -0.40 | -0.38 | -0.26 | Centessa Pharmaceuticals GAAP EPS of -$0.40 [8/13/2024 8:20 AM] |
10.89 | 0.34 (3.22%) |
10.55 | 0.0 (0.00%) |
5.15 - 12.45 | 402,795 | 210,000 | 113 | ||
28-03-2024 | AH | CNTA | Centessa Pharmaceuticals | 1,050 | -0.38 | -0.44 | 0.00 | Centessa Pharmaceuticals GAAP EPS of -$0.38 [3/28/2024 5:00 PM] |
11.30 | 0.20 (1.80%) |
11.30 | 0.0 (0.00%) |
3.52 - 12.45 | 171,515 | 260,000 | 845 | ||
13-11-2023 | PM | CNTA | Centessa Pharmaceuticals | 612.00 | -0.40 | -0.46 | 0.00 | Centessa Pharmaceuticals GAAP EPS of -$0.40 beats by $0.12 [11/14/2023 2:09 AM] |
6.80 | 0.56 (8.97%) |
0.0 | 0.0 (0.00%) |
3.00 - 8.65 | 22,322 | 190,000 | 0 | ||
14-08-2023 | PM | CNTA | Centessa Pharmaceuticals | 625.00 | -0.26 | -0.43 | 0.00 | Centessa Pharmaceuticals GAAP EPS of -$0.26 [8/14/2023 9:56 AM] |
6.70 | 0.03 (0.45%) |
0.0 | 0.0 (0.00%) |
3.00 - 8.65 | 70,883 | 340,000 | 0 | ||
12-05-2023 | PM | CNTA | Centessa Pharmaceuticals | 437.00 | -0.53 | -0.39 | 0.00 | Centessa Pharmaceuticals GAAP EPS of -$0.53 [5/12/2023 7:27 AM] |
4.69 | 0.06 (1.30%) |
0.0 | 0.0 (0.00%) |
2.88 - 6.23 | 95,724 | 130,000 | 0 | ||
30-03-2023 | PM | CNTA | Centessa Pharmaceuticals plc | 310.28 | -0.45 | -0.48 | -0.68 | Centessa Pharmaceuticals GAAP EPS of -$0.45 misses by $0.01 [3/30/2023 8:51 AM] |
3.87 | -0.03 (-0.77%) |
4.17 | 0.27 (6.92%) |
2.88 - 9.95 | 238,431 | 120,000 | 91,915 | ||
10-11-2022 | PM | 6:30 AM ET (Nov 10) |
CNTA | Centessa Pharmaceuticals | 319.00 | -0.57 | -0.49 | 0.00 | Centessa Pharmaceuticals GAAP EPS of -$0.57 [11/10/2022 9:23 AM] |
3.46 | 0.09 (2.67%) |
3.37 | 0.0 (0.00%) |
2.88 - 13.87 | 153,300 | 40,000 | 179 | |
10-08-2022 | PM | 7:00 AM ET (Aug 10) |
CNTA | Centessa Pharmaceuticals | 487.00 | -0.69 | -0.56 | 0.00 | Centessa Pharmaceuticals GAAP EPS of -$0.69 [8/10/2022 8:08 AM] |
4.71 | -0.30 (-5.99%) |
4.94 | -0.07 (-1.40%) |
2.88 - 25.98 | 89,707 | 120,000 | 1,727 | |